CollPlant Biotechnologies (CLGN) Long-Term Deferred Tax (2020 - 2022)

CollPlant Biotechnologies has reported Long-Term Deferred Tax for 3 years, with the latest figure at $22.5 million in Q4 2022.

• For the quarter ending Q4 2022, Long-Term Deferred Tax rose 36.2% year-over-year to $22.5 million; the trailing twelve-month figure through Dec 2022 stood at $22.5 million (up 36.2% YoY), and the FY2022 full-year result was $22.5 million, up 36.2% from the prior year.
• Long-Term Deferred Tax for Q4 2022 stood at $22.5 million, up from $16.5 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $22.5 million in Q4 2022, with the low at $15.5 million in Q4 2020.
• Historically, Long-Term Deferred Tax has averaged $18.2 million across 3 years, with a median of $16.5 million in 2021.
• Annual changes were most pronounced in 2021 — Long-Term Deferred Tax climbed 6.38% — and 2022, when it soared 36.2%.
• CollPlant Biotechnologies' Long-Term Deferred Tax stood at $15.5 million in 2020, then advanced by 6.38% to $16.5 million in 2021, then jumped by 36.2% to $22.5 million in 2022.
• The last three Long-Term Deferred Tax figures came in at $22.5 million (Q4 2022), $16.5 million (Q4 2021), and $15.5 million (Q4 2020), per Business Quant data.